The chemoadjuvant potential of grape seed procyanidins on p53-related cell death in oral cancer cells

Journal of Oral Pathology and Medicine

Volumn 41, Issue 4, 2012, Pages 322-331

  Lin, Yaoh Shiang ^a   Chen, Su Feng ^b   Liu, Chia Lin ^c   Nieh, Shin ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Apoptosis; Cell cycle; Grape seed procyanidins; Oral squamous cell carcinoma; P53

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; GELATINASE A; GELATINASE B; GRAPE SEED PROCYANIDIN; ONCOPROTEIN; PROCYANIDIN; PROTEIN BCL 2; PROTEIN P53; UNCLASSIFIED DRUG;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; MITOCHONDRION; MOUTH CANCER; ORAL SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; WILD TYPE;

ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL DEATH; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DOSE-RESPONSE RELATIONSHIP, DRUG; G1 PHASE; GRAPE SEED EXTRACT; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MITOCHONDRIA; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; ONCOGENE PROTEINS; PLANT PREPARATIONS; POINT MUTATION; PROANTHOCYANIDINS; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR SUPPRESSOR PROTEIN P53; VITIS;

EID: 84858701242     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2011.01103.x     Document Type: Article

References (54)

1. Chen YJ, Chang JT, Liao CT, et al. Head and neck cancer in the betel quid chewing area: recent advances in molecular carcinogenesis. Cancer Sci 2008; 99: 1507-14.
2. Olasz L, Szabó I, Horváth A. A combined treatment for advanced oral cavity cancers. Cancer 1988; 62: 1267-74.
3. Scully C, Bagan JV. Recent advances in oral oncology. Oral Oncol 2007; 43: 107-15.
4. Yuen AP, Wei WI, Lam LK, Ho WK, Kwong D. Results of surgical salvage of locoregional recurrence of carcinoma of the tongue after radiotherapy failure. Ann Otol Rhinol Laryngol 1997; 106: 779-82.
5. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene, clues to cancer etiology and molecular pathogenesis. Cancer Res 1994; 54: 4855-78.
6. Crowe DL, Sinha UK. p53 apoptotic response to dna damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines. Head Neck 2006; 28: 15-23.
7. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991; 51: 6304-11.
8. Kuerbitz SJ, Plunkett BS, Walsh WV, Kastan MB. Wildtype p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci U S A 1992; 89: 7491-5.
9. Lotem J, Sachs L. Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosis by some agents. Blood 1993; 82: 1092-6.
10. Bradford CR, Zhu S, Wolf GT, et al. Overexpression of p53 predicts organ preservation using induction chemotherapy and radiation in patients with advanced laryngeal cancer. Department of Veterans Affairs Laryngeal Cancer Study Group. Otolaryngol Head Neck Surg 1995; 113: 408-12.
11. Rowan S, Ludwig RL, Haupt Y, et al. Specific loss of apoptotic but not cell cycle arrest function in a human tumor derived p53 mutant. EMBO J 1996; 15: 827-38.
12. Ryan KM, Vousden KH. Characterization of structural p53 mutants which show selective defects in apoptosis but not cell cycle arrest. Mol Cell Biol 1998; 18: 3692-8.
13. Frei B, Higdon JV. Antioxidant activity of tea polyphenols in vivo: evidence from animal studies. J Nutr 2003; 133: 3275S-84S.
14. Luo J, Inoue M, Iwasaki M, et al. Green tea and coffee intake and risk of pancreatic cancer in a large-scale, population-based cohort study in Japan (JPHC study). Eur J Cancer Prev 2007; 16: 542-8.
15. Silva RC, Rigaud J, Cheynier V, Cheminat A, Moutounet M. Procyanidin dimers and trimers from grape seeds. Phytochemistry 1991; 30: 1259-64.
16. Prieura C, Rigauda J, Cheyniera V, Moutouneta M. Oligomeric and polymeric procyanidins from grape seeds. Phytochemistry 1994; 36: 781-9.
17. Frederiksen H, Mortensen A, Schrøder M, et al. Effects of red grape skin and seed extract supplementation on atherosclerosis in Watanabe heritable hyperlipidemic rabbits. Mol Nutr Food Res 2007; 51: 564-71.
18. Auger C, Gérain P, Laurent-Bichon F, et al. Phenolics from commercialized grape extracts prevent early atherosclerotic lesions in hamsters by mechanisms other than antioxidant effect. J Agric Food Chem 2004; 52: 5297-302.
19. Bagchi D, Bagchi M, Stohs S, et al. Cellular protection with proanthocyanidins derived from grape seeds. Ann N Y Acad Sci 2002; 957: 260-70.
20. Bagchi D, Sen CK, Ray SD, et al. Molecular mechanisms of cardioprotection by a novel grape seed proanthocyanidin extract. Mutat Res 2003; 523-524: 87-89.
21. Yamakoshi J, Kataoka S, Koga T, Ariga T. Vanthocyanidin-rich extract from grape seeds attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits. Atherosclerosis 1999; 142: 139-49.
22. Meeran SM, Katiyar SK. Grape seed proanthocyanidins promote apoptosis in human epidermoid carcinoma A431 cells through alterations in Cdki-Cdk-cyclin cascade, and caspase-3 activation via loss of mitochondrial membrane potential. Exp Dermatol 2007; 16: 405-15.
23. Akhtar S, Meeran SM, Katiyar N, Katiyar SK. Grape seed proanthocyanidins inhibit the growth of human non-small cell lung cancer xenografts by targeting insulin-like growth factor binding protein-3, tumor cell proliferation, and angiogenic factors. Clin Cancer Res 2009; 15: 821-31.
24. Eng ET, Ye J, Williams D, et al. Suppression of estrogen biosynthesis by procyanidin dimers in red wine and grape seeds. Cancer Res 2003; 63: 8516-22.
25. Mantena SK, Baliga MS, Katiyar SK. Grape seed proanthocyanidins induce apoptosis and inhibit metastasis of highly metastatic breast carcinoma cells. Carcinogenesis 2006; 27: 1682-91.
26. Dhanalakshmi S, Agarwal R, Agarwal C. Inhibition of NF-kappa B pathway in grape seed extract-induced apoptotic death of human prostate carcinoma DU145 cells. Int J Oncol 2003; 23: 721-7.
27. Tyagi A, Agarwal R, Agarwal C. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis. Oncogene 2003; 22: 1302-16.
28. Kaur M, Mandair R, Agarwa R, Agarwal C. Grape seed extract induces cell cycle arrest and apoptosis in human colon carcinoma cells. Nutr Cancer 2008; 60: 2-11.
29. Kaur M, Singh RP, Gu M, Agarwal R, Agarwal C. Grape seed extract inhibits in vitro and in vivo growth of human colorectal carcinoma cells. Clin Cancer Res 2006; 12: 6194-202.
30. Engelbrecht AM, Mattheyse M, Ellis B, et al. Proanthocyanidin from grape seeds inactivates the PI3-kinase/PKB pathway and induces apoptosis in a colon cancer cell line. Cancer Lett 2007; 258: 144-53.
31. Hsu CP, Lin YH, Chou CC, et al. Mechanisms of grape seed procyanidin-induced apoptosis in colorectal carcinoma cells. Anticancer Res 2009; 29: 283-9.
32. Yamakoshi J, Saito M, Kataoka S, Kikuchi M. Safety evaluation of proanthocyanidin-rich extract from grape seeds. Food Chem Toxicol 2002; 40: 599-607.
33. Ye X, Krohn RL, Liu W, et al. The cytotoxic effects of a novel IH636 grape seed proanthocyanidin extract on cultured human cancer cells. Mol Cell Biochem 1999; 96: 99-108.
34. Mittal A, Elmets CA, Katiyar SK. Dietary feeding of proanthocyanidins from grape seeds prevents photocarcinogenesis in SKH-1 hairless mice: relationship to decreased fat and lipid peroxidation. Carcinogenesis 2003; 24: 1379-88.
35. Katiyar SK. Matrix metalloproteinases in cancer metastasis: molecular targets for prostate cancer prevention by green tea polyphenols and grape seed proanthocyanidins. Endocr Metab Immune Disord Drug Targets 2006; 6: 17-24.
36. Chatelain K, Phippen S, McCabe J, Teeters CA, O'Malley S, Kingsley K. Cranberry and grape seed extracts inhibit the proliferative phenotype of oral squamous cell carcinomas. Evid Based Complement Alternat Med 2011; 2011: 1-12.
37. Kim MS, Li SL, Bertolami CN, Cherrick HM, Park NH. State of p53, Rb and DCC tumor suppressor genes in human oral cancer cell lines. Anticancer Res 1993; 13: 1405-13.
38. Chung YC, Lin CC, Chou CC, Hsu CP. The effect of Longan seed polyphenols on colorectal carcinoma cells. Eur J Clin Invest 2010; 40: 713-21.
39. Hsu CP, Lin YH, Zhou SP, Chung YC, Lin CC, Wang SC. Longan flower extract inhibits the growth of colorectal carcinoma. Nutr Cancer 2010; 62: 229-36.
40. Kuo SM. Dietary flavonoid and cancer prevention: evidence and potential mechanism. Crit Rev Oncog 1997; 8: 47-69.
41. Stan SD, Kar S, Stoner GD, Singh SV. Bioactive food components and cancer risk reduction. J Cell Biochem 2008; 104: 339-56.
42. Marshall JR. Prevention of colorectal cancer: diet, chemoprevention, and lifestyle. Gastroenterol Clin North Am 2008; 37: 73-82.
43. Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 2003; 3: 768-80.
44. Ariga T. The antioxidative function, preventive action on disease and utilization of proanthocyanidins. Biofactors 2004; 21: 197-201.
45. Bagchi D, Bagchi M, Stohs SJ, et al. Free radicals and grape seed proanthocyanidin extract: importance in human health and disease prevention. Toxicology 2000; 148: 187-97.
46. Katiyar SK. Grape seed proanthocyanidines and skin cancer prevention: inhibition of oxidative stress and protection of immune system. Mol Nutr Food Res 2008; 52(Suppl 1): S71-6.
47. Wen W, Lu J, Zhang K, Chen S. Grape seed extract inhibits angiogenesis via suppression of the vascular endothelial growth factor receptor signaling pathway. Cancer Prev Res (Phila) 2008; 1: 554-61.
48. Reed JC. Balancing cell life and death: bax, apoptosis, and breast cancer. J Clin Invest 1996; 97: 2403-7.
49. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998; 28: 1309-12. Review.
50. Reed JC, Miyashita T, Takayama S, et al. BCL-2 family proteins: regulators of cell death involved in the pathogenesis of cancer and resistance to therapy. J Cell Biochem 1996; 60: 23-32.
51. Bloomston M, Zervos EE, Rosemurgy AS II. Matrix metalloproteinases and their role in pancreatic cancer: a review of preclinical studies and clinical trials. Ann Surg Oncol 2002; 9: 668-74.
52. Chresta CM, Masters JR, Hickman JA. Hypersensitivity of human testicular tumors to etoposide-induced apoptosis is associated with functional p53 and a high Bax:Bcl-2 ratio. Cancer Res 1996; 56: 1834-41.
53. La VD, Bergeron C, Gafner S, Grenier D. Grape seed extract suppresses lipopolysaccharide-induced matrix metalloproteinase (MMP) secretion by macrophages and inhibits human MMP-1 and -9 activities. J Periodontol 2009; 80: 1875-82.
54. Yoon SO, Shin S, Mercurio AM. Ras stimulation of E2F activity and a consequent E2F regulation of integrin alpha6beta4 promote the invasion of breast carcinoma cells. Cancer Res 2006; 66: 6288-95.